Global Small Interfering RNA (siRNA) Market Research Report 2025

Publication ID:

PB504259592

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Small Interfering RNA (siRNA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP"s advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
North American market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Interfering RNA (siRNA) in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Interfering RNA (siRNA) include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Interfering RNA (siRNA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Interfering RNA (siRNA).
The Small Interfering RNA (siRNA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Interfering RNA (siRNA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Interfering RNA (siRNA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Chemical Synthesis of siRNA
1.2.3 Sterol Modified Chemical Synthesis of siRNA
1.3 Market by Application
1.3.1 Global Small Interfering RNA (siRNA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Interfering RNA (siRNA) Market Perspective (2020-2031)
2.2 Global Small Interfering RNA (siRNA) Growth Trends by Region
2.2.1 Global Small Interfering RNA (siRNA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Interfering RNA (siRNA) Historic Market Size by Region (2020-2025)
2.2.3 Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031)
2.3 Small Interfering RNA (siRNA) Market Dynamics
2.3.1 Small Interfering RNA (siRNA) Industry Trends
2.3.2 Small Interfering RNA (siRNA) Market Drivers
2.3.3 Small Interfering RNA (siRNA) Market Challenges
2.3.4 Small Interfering RNA (siRNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Players by Revenue
3.1.1 Global Top Small Interfering RNA (siRNA) Players by Revenue (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Revenue Market Share by Players (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Interfering RNA (siRNA) Revenue
3.4 Global Small Interfering RNA (siRNA) Market Concentration Ratio
3.4.1 Global Small Interfering RNA (siRNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Revenue in 2024
3.5 Global Key Players of Small Interfering RNA (siRNA) Head office and Area Served
3.6 Global Key Players of Small Interfering RNA (siRNA), Product and Application
3.7 Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Interfering RNA (siRNA) Breakdown Data by Type
4.1 Global Small Interfering RNA (siRNA) Historic Market Size by Type (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031)
5 Small Interfering RNA (siRNA) Breakdown Data by Application
5.1 Global Small Interfering RNA (siRNA) Historic Market Size by Application (2020-2025)
5.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Interfering RNA (siRNA) Market Size (2020-2031)
6.2 North America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
6.4 North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Interfering RNA (siRNA) Market Size (2020-2031)
7.2 Europe Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
7.4 Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Interfering RNA (siRNA) Market Size (2020-2031)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Interfering RNA (siRNA) Market Size (2020-2031)
9.2 Latin America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
9.4 Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Interfering RNA (siRNA) Market Size (2020-2031)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Small Interfering RNA (siRNA) Introduction
11.1.4 Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Small Interfering RNA (siRNA) Introduction
11.2.4 Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 NanoString Technologies, Inc.
11.4.1 NanoString Technologies, Inc. Company Details
11.4.2 NanoString Technologies, Inc. Business Overview
11.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.4.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.4.5 NanoString Technologies, Inc. Recent Development
11.5 Dharmacon (Horizon Discovery Group)
11.5.1 Dharmacon (Horizon Discovery Group) Company Details
11.5.2 Dharmacon (Horizon Discovery Group) Business Overview
11.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Introduction
11.5.4 Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.5.5 Dharmacon (Horizon Discovery Group) Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Small Interfering RNA (siRNA) Introduction
11.6.4 Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.6.5 Synlogic Recent Development
11.7 GeneCopoeia, Inc.
11.7.1 GeneCopoeia, Inc. Company Details
11.7.2 GeneCopoeia, Inc. Business Overview
11.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Introduction
11.7.4 GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.7.5 GeneCopoeia, Inc. Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Details
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Small Interfering RNA (siRNA) Introduction
11.8.4 New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.8.5 New England Biolabs Recent Development
11.9 Quantabio
11.9.1 Quantabio Company Details
11.9.2 Quantabio Business Overview
11.9.3 Quantabio Small Interfering RNA (siRNA) Introduction
11.9.4 Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.9.5 Quantabio Recent Development
11.10 NanoString Technologies, Inc.
11.10.1 NanoString Technologies, Inc. Company Details
11.10.2 NanoString Technologies, Inc. Business Overview
11.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.10.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.10.5 NanoString Technologies, Inc. Recent Development
11.11 BioGenex
11.11.1 BioGenex Company Details
11.11.2 BioGenex Business Overview
11.11.3 BioGenex Small Interfering RNA (siRNA) Introduction
11.11.4 BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.11.5 BioGenex Recent Development
11.12 SeqMatic LLC
11.12.1 SeqMatic LLC Company Details
11.12.2 SeqMatic LLC Business Overview
11.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Introduction
11.12.4 SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.12.5 SeqMatic LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂